首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for polypoidal choroidal vasculopathy: A systematic review and meta-analysis
【24h】

Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for polypoidal choroidal vasculopathy: A systematic review and meta-analysis

机译:光动力疗法联合兰尼单抗与兰尼单抗单药治疗息肉样脉络膜血管病:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To perform a systematic review and meta-analysis to compare the outcome and serious adverse effects of intravitreal ranibizumab (IVR) monotherapy vs. combined treatment of IVR and photodynamic therapy (PDT) on polypoidal choroidal vasculopathy (PCV).
机译:目的:进行系统评价和荟萃分析,以比较玻璃体内雷珠单抗(IVR)单一疗法与IVR和光动力疗法(PDT)联合治疗对脉络膜脉络膜血管病(PCV)的结果和严重不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号